On September 19, 2023 Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase ib Clinical Trial Targeting Healthy Young Women
On October 6, 2022 Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naive adults
On September 26, 2022 Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon
On November 18, 2021 Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
On October 1, 2021 Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon
On June 25, 2021 Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy
